PEGylated Proteins Market by Consumables 2025 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

PEGylated Proteins Market
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies) - Global Forecast to 2017 - 2025
Report Code : HCR 0449
Updated Date: 30 April, 2018  

  • Report Description
  • Table of Contents
  • Customization Options
PEGylation is the covalent coupling of non-toxic, hydrophilic polyethylene glycol (PEG) to dynamic pharmaceutical elements such as proteins, peptides, antibodies, colloids and others. PEGylation is routinely accomplished by incubation of a reactive derivative of PEG with the target molecule. PEGylation raises strength and solubility of the drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the particle. The rise in adoption of PEGylation to treat various chronic diseases and the applications in PEGylation is the key factor that is driving the PEGylation market. PEGylation market was valued at a revenue of $XXm in 2016 and is estimated to reach $XXm in 2022 with an anticipated growth at a CAGR of XX% during 2017-2022. 

PEGylation is the process of suitable functionalization of the PEG polymer at one or both terminals. PEGs that are actuated at every end with the same responsive half are known as "homobifunctional", though if the useful gatherings present are distinctive, then the PEG derivative is referred as "heterofunctional." The chemically dynamic or activated derivatives of the PEG polymers are set up to attach the PEG to the desired molecule. PEGylated proteins have wide applications and preferences over traditional treatment, as a result, the adoption is high. Failure of drug development and recall of products are the factors which will affect the PEGylated proteins market.

PEGylated proteins market is divided into four different geographic regions. North America and Europe are the major markets for PEGylated proteins. Countries in these regions are well developed and patients are very conscious about the diseases and available treatments. Increasing prevalence of chronic diseases and rise in health care spending are expected to drive the market in Asia-Pacific.

Sample Companies Profiled in this Report are:
  • Merck Millipore (U.S.), 
  • NOF Corporation (Japan), 
  • Celares GmbH (Germany), 
  • Biomatrik, Inc, (China), 
  • Thermo Fisher Scientific, Inc. (U.S.)
  • 10+
1.PEGylated Proteins Market Overview
2.PEGylated Proteins Market Executive Summary
3.PEGylated Proteins Market Landscape
  3.1 Market Share Analysis
  3.2 Product Benchmarking
  3.3 End User Profiling
  3.4 Patent Analysis
  3.5 Top 5 Financial Analysis
4.PEGylated Proteins Market Forces
  4.1 Market Drivers
  4.2 Market Restraints & Challenges
  4.3 Opportunities
  4.4 Porter’s Five Forces Analysis 
       4.4.1 Power of Suppliers
       4.4.2 Power of Buyers
       4.4.3 Threat of New Entrants 
       4.4.4 Threat of Substitution 
       4.4.5 Degree of Competition
5.PEGylated Proteins Market – Strategic Analysis
  5.1 Value Chain Analysis
  5.2 Pricing Analysis
  5.3 Product/Market Life Cycle Analysis
  5.4 Suppliers & Distributors
6.PEGylated Proteins Market - By Consumables
  6.1 Introduction
  6.2 PEGylation Kits
  6.3 Reagents
7.PEGylated Proteins Market - By Services, Protein Type
  7.1 Introduction
  7.2 mAbs
  7.3 Interferons
8.PEGylated Proteins Market - By Application
  8.1 Introduction
  8.2 Cancer Treatment
  8.3 Chronic Kidney Diseases
9.PEGylated Proteins Market- By End-User
  9.1 Introduction
  9.2 Pharmaceutical
  9.3 Biotechnology Companies
10.PEGylated Proteins Market- By Geography
  10.1 Introduction
  10.2 North America
       10.2.1 U.S.
       10.2.2 Canada
  10.3 Europe
       10.3.1 U.K.
       10.3.2 Germany 
       10.3.3 France
       10.3.4 Italy
       10.3.5 Rest of Europe
  10.4 Asia Pacific
       10.4.1 China
       10.4.2 Japan
       10.4.3 India
       10.4.4 Rest of Asia-Pacific
  10.5 Rest of the World (RoW)
       10.5.1 South America
       10.5.2 Middle East
       10.5.3 Africa
11.PEGylated Proteins Market Entropy
12.Company Profiles
    12.1 Merck Millipore 
    12.2 Thermo Fisher Scientific Inc. 
    12.3 NOF American Corporation
    12.4 Jenkem Technology
    12.5 Creative Pegworks
    12.6 Celares GmbH 
    12.7 Quanta Biodesign, Ltd 
    12.8 Biomatrik, Inc. 
     12.9 Iris Biotech GmbH
     12.10 Laysan Bio, Inc.
 *More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports